Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Glenmark Pharmaceuticals Limited
Press Release Nov 23 2020
Published Nov 23 2020
3 min read

Press Release Nov 23 2020

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 23, 2020, titled "Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure".

View Attachment